University of Dundee researchers hope to turn their spinout venture into a biotech company worth hundreds of millions of pounds by helping to treat people with eczema, rheumatoid arthritis and other inflammatory conditions. In4Derm Ltd is an innovative drug discovery company developing the next generation of...
Opportunity North East (ONE) is launching a new programme to help translate life sciences research and ideas into growth businesses that positively impact healthcare delivery and patient outcomes. The programme of four 90-minute online workshops will help researchers, clinicians and potential entrepreneurs to start their commercialisation journeys. ONE...
BioCity 2019 Accelerator programme graduate company, Myndr, has secured six-figure funding from the government’s business innovation programme. Myndr, which is based in Newcastle, has received £300k investment from Innovate UK to expand its proposition. Founded by Lizzy Hodcroft and Emma Reilly, Myndr aims to create an anonymous platform,...
Friday 06 December, Nottingham, England UK. At a black-tie event held in Nottingham last night, 200 leading names and rising stars of the life sciences came together at the Medilink East Midlands Business Awards 2019. A celebration of innovation within the region, a total of seven...
Coronary heart disease is one of the leading causes of death within the UK. Every day over 2500 patients present at A&E departments across the UK with chest pain, indicative of a suspected heart attack. Of these, only 20% will have a confirmed heart attack....
The Converge Awards, Scotland’s annual celebration of academic innovation and entrepreneurship for staff, students and recent graduates across all Scottish Universities, took place on Wednesday 25 September at the spectacular V&A in Dundee. The annual quest to find the country’s most promising academic entrepreneurs with innovative...
Cheshire UK, 29 August 2019 BioCity, the pioneering life science incubator and business collective, has today announced investment in precision medicine biotech, Kinomica Ltd., via the Innovate UK Precision Medicine Investment Accelerator. Spun out from Barts Cancer Institute, Queen Mary University of London, Kinomica Ltd is an...
BioCity, a pioneering life science incubator and business collective, today announced investment in Deep Branch Biotechnology, a Nottingham-based carbon recycling start-up, developing technology that transforms polluters into producers. Unlike traditional carbon storage technology that simply collects and stores carbon dioxide, Deep Branch’s carbon recycling solution converts...
BioCity, the UK’s largest life science incubator has been appointed by Newcastle City Council to run a life science accelerator and business support programme from The Biosphere, which is based on Newcastle Helix. The programme is being delivered by BioCity from The Biosphere, a brand...
BioCity is set to further expand operations following its appointment to run a new bespoke accelerator programme in Aberdeen. The accelerator programme is being launched to catalyse growth in Aberdeen’s world-class life sciences cluster by supporting the development of start-ups, spin-outs and growth companies across the...